Clinical Trials - Division of Research and Education
Other Clinical Trials
Scott & White also conducts clinical trials through the following departments:
- Cancer Research Institute (T-cell lymphoma, AML, Non-Hodgkin's lymphoma)
- Cancer Institute
Additional Resources
- MedlinePlus
- Access to medical information in both English and Español
- ClinicalTrials.gov
- Access to regulations involving clinical studies and glossary of terminology with definitions used in clinical trials
- Find maps and directions on how to get to Scott & White
Scott & White continuously undertakes clinical trials sponsored by various organizations. These clinical trials are governed by specific, nationally supported scientific and ethical regulations. These regulations are clearly expressed so that the general population may understand what is involved when participating in a clinical trial.
Clinical trials through Research and Education are found in various medical areas that are easily broken down into specific categories.
All categories are updated regularly to include currently enrolling studies. Any changes observed are reflected in the inclusion or omission of specific categories with their respective studies.
Clinical trials can be found in the following categories:
Anesthesia
#8761
Title: Spinal 2-Chloroprocaine: A comparison with bupivacaine (spinal anesthetic) for post-partum tubule ligation.
Eligible subjects: Females at least 18 years of age and scheduled for elective post-partum bilateral tubule ligation.
#81620
Title: A Double-Blind, Multi-Center, Randomized, Stratified, Parallel, 2 Arm, Phase 2 Study to Assess Palonosetron vs. Ondansetron as Rescue in Subjects that Developed Postoperative Nausea and Vomiting (PONV) in the Postanesthesia Care Unit (PACU)
Eligible subjects: Men and Women that are 18 years of age or older. Current non-smokers who are scheduled to undergo elective laparoscopic abdominal or gynecological surgery and have a history of Post Operative Nausea and Vomiting (PONV)
Bone, Joint and Muscles
#8726
Title: Proteomic Analysis of normal Versus osteoporotic Bone.
Eligible subjects: All postmenopausal females between the ages of 18 years and 85 years.
#90081
Title: A study to assess the effectiveness of a new drug for the treatement of patients with Rheumatoid Arthritis.
Eligible subjects: Men and women, 18 years of age to 75 years of age, who have a current diagnosis of active RA, currently receiving a traditional DMARD, and have never been treated with a biologic DMARD.
Brain and Nervous system
#60733
Title: Parkinson Disease (PD) Quality of Life Pilot
Eligible subjects: Men and women from 21 to 85 years of age with a documented diagnosis of idiopathic Parkinson Disease. Subjects must be seen by a Scott & White neurologist at the Plummer Movement Disorders Center at S&W for their Parkinson Disease, be able to walk and be in middle stage of the disease process.
#71326
Title: "Stenting and Aggressive Medical Managment for Prventing Recurrent stroke in Intracranial Stenosis (SAMMPRIS)."
Eligible subjects: Male and Femles, between 30-80 years of age that have had a transient ischemic attack (TIA) or non-severe stroke within the last 30 days. The stroke or TIA must be attributed to stenosis of a major intracranial artery.
Back to TopDigestive system
#8896
Title: A study to determine if not placing a feeding tube directly into the stomach after pancreatic surgery has an effect on postoperative progress and hospital stay.
Eligible subjects: Are 18 years of age or older scheduled for pancreatic surgery.
Endocrinology
#81644
Title: Targeting Inflammation Using Salsalate in Type II Diabetes (TINSAL T2D).
Eligible subjects: Male and Female patients between 18 and 74 years of age with HbA1c levels between 7 and 9.5 and who are not on insulin therapy.
Eye
#8727
Title: Deep lamellar endothelial keratoplasty study for corneal transplants.
Eligible subjects: At least 18 years old or older with endothelial dysfunction scheduled for standard penetrating keratoplasty.
Heart, Blood, Vessels
Cath Lab Studies
Drug Studies
#50275
Title: A comparison of two drugs, Vytorin ® and Zocor ®, in their effectiveness to lower blood cholesterol levels.
Eligible subjects: Men and women recently recovered from acute coronary syndrome (ACS).
Lipid - Cholesterol Studies
#50275
Title: A comparison of two drugs, Vytorin ® and Zocor ®, in their effectiveness to lower blood cholesterol levels.
Eligible subjects: Men and women recently recovered from acute coronary syndrome (ACS).
Kidney, Liver
#50077
Title: Health and Literacy in Child and Adult Assessment.
Eligible subjects: Children and adolescents from the ages of 8 to 17 with any of the following: Attention Deficit/Hyperactivity Disorder (ADHD), Obesity, Asthma or no chronic conditions (healthy).
#1466
Title: KABI International Growth Study (KIGS).
Eligible subjects: Identified as having inadequate growth hormone secretion.
#8815
Title: A study to assess the efficacy and safety of Bicalutamide when used in combination with Anastrozole for the treatment of Gonadotropin-independent Precocious Puberty in boys with Testoxicosis.
Eligible subjects: Males 2 years and older with the condition of Testotoxicosis, early puberty.
Lungs
#50077
Title: Health and Literacy in Child and Adult Assessment.
Eligible subjects: Children and adolescents from the ages of 8 to 17 with any of the following: Attention Deficit/Hyperactivity Disorder (ADHD), Obesity, Asthma or no chronic conditions (healthy).
#81461
Title: A study of Sitaxsentan Sodium in Subjects with Pulmonary Arterial Hypertension.
Eligible subjects: Men and women, 18-80 years of age, who have a current diagnosis of pulmonary arterial hypertension (PAH). You must be able to perform a 6 minute walk test and walk a distance of 150 meters (about 500 feet).
Mental Health
No open studies at this time.
Obstetrics/Gynecology
#8761
Title: Spinal 2-Chloroprocaine: A comparison with bupivacaine (spinal anesthetic) for post-partum tubule ligation.
Eligible subjects: Females at least 18 years of age and scheduled for elective post-partum bilateral tubule ligation.
#8959
Title: Patient and surgeon expectations in pelvic floor dysfunction: Do they match and does it matter?
Eligible subjects: Women undergoing pelvic floor dysfunction surgery.
Pediatrics
#50077
Title: Health and Literacy in Child and Adult Assessment, Parent Proxy
Eligible subjects: Scott and White patients ages 8 thru 17 and their parent/guardian. Parents/guardians of Scott and White patients ages 5 thru 7.
#50286
Title: Safety and efficacy evaluation of Topical Moxidex Otic Solution compared to Moxifloxacin Solution in the treatment of Acute Otitis Media with Otorrhea through Tympanostomy Tubes (AOMT).
Eligible subjects: Males and females between the ages of six months and 12 years if they have had ear drainage for less than 21 days and also have tympanostomy tubes.
#1466
Title: KABI International Growth Study (KIGS).
Eligible subjects: Identified as having inadequate growth hormone secretion.
#71232
Title: The effect of a Probiotic containing infant formula on local markers of immunity and gut health.
Eligible subjects: Healthy infants 2-6 weeks old, formula fed or breastfed, male or female.
#8607
Title: Computer-assisted health related quality of life assessment in pediatric endocrinology.
Eligible subjects: Between the ages of two and 18, evaluated and/or treated through the Scott & White Pediatric Endocrinology Clinic.
Surgery
#8896
Title: A study to determine if not placing a feeding tube directly into the stomach after pancreatic surgery has an effect on postoperative progress and hospital stay.
Eligible subjects: Are 18 years of age or older scheduled for pancreatic surgery.
Urology
#70885
Title: Prospective, Multicenter, Randomized, Parallel-Group Trial, Comparing the Safety and Efficacy of InterStim® Therapy to Standard Medical Therapy for Subjects with Symptoms of Overactive Bladder.
Eligible subjects: Males and Females 18 years and older with a diagnosis of overactive bladder including urinary urge incontinence OR urinary urgency-frequency.
#81555
Title: Post-Approval study of Coaptite® in the treatment of female urinary incontinence.
Eligible subjects: Females 18 years and older.
Research & Education
Health Care Professionals
Patients